Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
ZHAOKE OPHTH-B: Registration Application for 0.02% Atropine Sulfate Eye Drops Accepted for Evaluation by Australian TGA
Recommend 4 Positive 4 Negative 0 |
||||
|
||||
|
ZHAOKE OPHTH-B (06622.HK) announced that the Company’s registration application for its Atropine Sulfate Eye Drops (0.02% strength, product code: NVK002), for the treatment to slow the progression of myopia in children, has been accepted for evaluation by the Therapeutic Goods Administration (TGA) of Australia. The TGA has formally acknowledged that the Company’s application has passed a preliminary assessment and will proceed to evaluation. This application is based on positive data from the Phase III clinical trial conducted by the Company. AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
